Diabetes mellitus in the context of COVID-19
Keywords:
Diabetes, Mellitus diabetes, Coronavirus Infections, SARS-Cov-2Abstract
A high prevalence of diabetes mellitus (DM) represents a challenge during the coronavirus disease 2019 (COVID-19) pandemic. DM represents an important risk factor for adverse outcomes in patients with COVID-19.
Objective: to describe the clinical, epidemiological and molecular characteristics; including treatment options among patients with COVID-19 and diabetes mellitus.
Method: a literature review was conducted in articles published by peer-reviewed journals up to June 2020. SciELO and PubMed databases were screened in search of articles. The search terms included diabetes mellitus, coronavirus infection, and its Spanish translation “diabetes mellitus”, “infección por coronavirus”.
Development: COVID-19 and diabetic patients may be predisposed to immune dysfunction that results in severe late illness. Most patients with mild infection can continue with the usual antihyperglycemic medications. The result of the use of corticosteroids is not yet clear. There are safety concerns regarding treatment with chloroquine/hydroxychloroquine, due to its hypoglycemic role and adverse effects.
Conclusions: the molecular and pathophysiological mechanisms between COVID-19 and diabetes mellitus are still not fully understood. The poor prognosis observed in these patients requires the creation of a novel treatment protocol.
Downloads
References
1. Paules CI, Marston HD, Fauci AS. Coronavirus Infections—More Than Just the Common Cold. JAMA [Internet]. 2020 [Cited 25 June 2020];323(8):707-8. Available from: https://jamanetwork.com/journals/jama/fullarticle/2759815
2. Muniyappa R, Gubbi S. COVID-19 pandemic, coronaviruses and diabetes mellitus. Am J Physiol Endocrinol Metab [Internet]. 2020 Mar [Cited 25 June 2020]; 318(5): [About 6 p.]. Available from: https://journals.physiology.org/doi/pdf/10.1152/ajpendo.00124.2020
3. Katulanda P, Dissanayake HA, Ranathuga I, Ratnasamy V, Wijewickrama PSA, et. al. Prevention and management of COVID-19 among patients with diabetes: an appraisal of literature. Diabetologia [Internet] 2020 May [Cited 25 June 2020]; 63(2020): 1440-1452: [Aprox. 13p.] Disponible desde: https://link.springer.com/article/10.1007/s00125-020-05164-x
4. Infomed. Information note on COVID-19 in Cuba: June 21 [Internet]. Havana: National Center for Information on Medical Sciences. [Actualized June 21, 2020; cited 22 June 2020] Available from: https://temas.sld.cu/coronavirus/2020/06/22/nota-informativa-sobre-la-covid-19-en-cuba-21-de-junio/
5. Bello-Chavolla OY, Bahena-Lopez JP. Predicting mortality due to SARS-Cov-2: A mechanistic score relating obesity and diabetes to COVID-19 outcomes in México. Jour Clin Endo Meta [Internet]. 2020 May [Cited 25 June 2020]; 105(8) [About 28 p.] Available from: https://academic.oup.com/jcem/article/105/8/dgaa346/5849337
6. Iacobellis G. COVID-19 and Diabetes: can DPP4 inhibition play a rol? Diabetes Res Clin Pract [Internet]. 2020 Mar [Cited 27 Abr 2020]; 162(2020): [About 8 p.]. Available from: https://www.diabetesresearchclinicalpractice.com/article/S0168-8227(20)30375-2/fulltext
7. Huang I, Lim MA, Pranata R. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia: A systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr [Internet]. 2020 Abr [Cited 25 June 2020]; 14(4): [About 22 p.]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7162793/
8. Drucker DJ. Coronavirus infections and type 2 diabetes-shared pathways with therapeutic implications. Endocr Rev [Internet]. 2020 June [Cited 25 Jun 2020]; 41(3): [About 28 p.]. Available from: http://samin.es/wp-content/uploads/2020/04/bnaa011.pdf
9. Guo W, Li M, Dong Y, Zhou H, Zhang Z, Tian C, et al. Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev [Internet]. 2020 April [Cited 25 June 2020]; 7(e3319): [About 9 p.]. Available from: https://onlinelibrary.wiley.com/doi/full/10.1002/dmrr.3319
10. Kumar Singh A, Gupta R, Gosh A, Misra A. Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations. Diabetes Metab Syndr. [Internet]. 2020 April. [Cited 25 June 2020]; 14(4): [About 7 p.]. Available from: https://www.sciencedirect.com/science/article/abs/pii/S1871402120300631
11. Pal R, Bhadada SK. COVID-19 and diabetes mellitus: An unholy interaction of two pandemics. Diab Met Res Rev. [Interntet]. 2020 July. [Cited 25 June 2020]; 14(4) [About 15 p.]. Available form: doi: https://www.sciencedirect.com/science/article/pii/S1871402120301144
12. Hussin A, Rothan E, Siddappa N, Byrareddy T. The epidemiology and pathogenesis of coronavirus disease (COVID-19). Outbreak Journal of Autoimmunity [Internet]. 2020 [Cited 25 June 2020]; 102(433): [About 1 p.]. Available from: https://www.sciencedirect.com/science/article/pii/S0896841120300469
13. Rodriguez-Morales A. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Medicine and Infectious Disease [Internet]. 2020 Mar [Cited 25 June 2020]; 30(40): [About 2 p.]. Available from: https://www.sciencedirect.com/science/article/pii/S1477893920300910
14. Singh AK, Singh A, Shaikh A, Singh R, Misra A. Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries. Diab Met Res Rev [Internet]. 2020 May-June [Cited 25 Abr 2020]; 14(3): [About 7 p.]. Available from: https://www.sciencedirect.com/science/article/pii/S1871402120300515
15. Bornstein SR, Rubino F, Khunti K. Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diab Endocrinol [Internet]. 2020 April [Cited 25 June 2020]; 8(546-50): [About 4 p.]. Available from: https://www.thelancet.com/journals/landia/article/PIIS2213-8587(20)30152-2/fulltext
16. Bornstein SR, Delan R, Hopkins D, Mingrone G, Boehm BO. El vínculo endocrino y metabólico de COVID-19. Nat Rev Endocrinol [Internet]. 2020 June [Cited 25 June 2020]; 16(297-298): [About 10 p.] Available from: https://www.nature.com/articles/s41574-020-0353-9
17. Guandi L, De Clercq E. Therapeutic options for the 2019 novel coronavirus (2019-nCov). Nature Reviews Drug Discovery [Internet]. 2020 [Cited 25 June 2020]; 19:149-50: [About 2 p.]. Available from: https://media.nature.com/original/magazine-assets/d41573-020-00016-0/d41573-020-00016-0.pdf
18. Gupta R, Hussain A, Misra A. Diabetes and COVID-19: evidence, current status and unanswered research questions. Eur J Clin Nutr. [Internet]. 2020 May. [Cited 25 June 2020]; 74(864-870): [Aprox. 7 p]. Available from: https://www.nature.com/articles/s41430-020-0652-1
19. Stoian AP, Banerjee Y, Rizvi AA, Rizzo M. Diabetes and the COVID-19 Pandemic: How Insights from Recent Experience Might Guide Future Management. Metab Syndr Relat Disord [Internet]. 2020 [Cited 25 June 2020]; 18(4): [About 4 p.]. Available from: https://www.liebertpub.com/doi/full/10.1089/met.2020.0037
20. Pal R, Bhadada SK. Should anti-diabetic medications be reconsidered amid COVID-19 pandemic? Diabetes Res Clin Pract [Internet]. 2020 May [Cited 25 June 2020]; 163(108146): [About 5 p.]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151403/
Published
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms: authors retain their copyright and grant the journal the right of first publication of their work, which is simultaneously subject to the Creative Commons Attribution-NonCommercial 4.0 International License that allows third parties to share the work as long as the author and first publication in this journal are indicated, for non-commercial use. Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional telematic archive or publishing it in a monographic volume) as long as the initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work via the Internet (e.g., in institutional telematic archives, in their web page or in Pre-print servers) before and during the submission process, which can lead to interesting exchanges and increase citations of the published work. (See The Open Access Effect).
